Tara Bancroft is an analyst at TD Cowen. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/16/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 05/08/2024 | OCUL | Buy Now | Ocular Therapeutix | $6.29 | 11.29% | $11 → $7 | Maintains | Hold | Get Alert |
| 04/29/2024 | GERN | Buy Now | Geron | $3.89 | 157.07% | → $10 | Initiates | → Buy | Get Alert |
| 04/16/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | $21.54 | — | — | Downgrade | Buy → Hold | Get Alert |
| 03/12/2024 | OCUL | Buy Now | Ocular Therapeutix | $6.29 | 74.88% | $8 → $11 | Maintains | Market Perform | Get Alert |
| 01/16/2024 | HARP | Buy Now | Harpoon Therapeutics | — | — | — | Downgrade | Outperform → Market Perform | Get Alert |
| 11/20/2023 | HARP | Buy Now | Harpoon Therapeutics | — | — | — | Initiates | → Outperform | Get Alert |
| 08/21/2023 | MRUS | Buy Now | Merus | $45.21 | — | — | Initiates | → Outperform | Get Alert |
| 08/31/2022 | BCYC | Buy Now | Bicycle Therapeutics | $22.36 | — | — | Initiates | → Outperform | Get Alert |
